Immune Globulin Subcutaneous (Human) (Octapharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameImmune Globulin Subcutaneous (Human) (Octapharma)
Drug Alias NameIGSCIGIMImmune globulin 16.5%GammanormOctanorm +[6] 
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunostimulantsBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsImmunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesDermatomyositis
Global Approved IndicationsImmunologic Deficiency Syndromes
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2018/08/02
Country/TerritoryCzechiaCanadaUnited States +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOctapharma
China Registration ClassN/A

Develop Information

Active CompaniesOctapharma
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency SyndromesPrimary Immunodeficiency Diseases
Inactive IndicationsDermatomyositis

Other Information

ATC CodeJ06BA01
Related LinksN/A